IL208793A0 - Novel class of spiro piperidines for the treatment of neurodegenerative diseases - Google Patents
Novel class of spiro piperidines for the treatment of neurodegenerative diseasesInfo
- Publication number
- IL208793A0 IL208793A0 IL208793A IL20879310A IL208793A0 IL 208793 A0 IL208793 A0 IL 208793A0 IL 208793 A IL208793 A IL 208793A IL 20879310 A IL20879310 A IL 20879310A IL 208793 A0 IL208793 A0 IL 208793A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- neurodegenerative diseases
- novel class
- spiro piperidines
- piperidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5042308P | 2008-05-05 | 2008-05-05 | |
| PCT/IB2009/051815 WO2009136350A1 (en) | 2008-05-05 | 2009-05-04 | Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL208793A0 true IL208793A0 (en) | 2010-12-30 |
Family
ID=40902870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL208793A IL208793A0 (en) | 2008-05-05 | 2010-10-18 | Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20110046160A1 (enExample) |
| EP (1) | EP2300484B1 (enExample) |
| JP (1) | JP2011519913A (enExample) |
| KR (1) | KR20110000749A (enExample) |
| CN (1) | CN102083841A (enExample) |
| AP (1) | AP2010005456A0 (enExample) |
| AT (1) | ATE537178T1 (enExample) |
| AU (1) | AU2009245322B2 (enExample) |
| BR (1) | BRPI0912433A2 (enExample) |
| CA (1) | CA2721786A1 (enExample) |
| CO (1) | CO6321280A2 (enExample) |
| CR (1) | CR11759A (enExample) |
| DO (1) | DOP2010000317A (enExample) |
| EA (1) | EA201001566A1 (enExample) |
| EC (1) | ECSP10010597A (enExample) |
| ES (1) | ES2375913T3 (enExample) |
| IL (1) | IL208793A0 (enExample) |
| MA (1) | MA32290B1 (enExample) |
| MX (1) | MX2010012066A (enExample) |
| NZ (1) | NZ588589A (enExample) |
| SV (1) | SV2010003725A (enExample) |
| WO (1) | WO2009136350A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| WO2011125006A2 (en) * | 2010-04-09 | 2011-10-13 | Pfizer Inc. | Novel sultam compounds |
| EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| US9221839B2 (en) | 2011-04-07 | 2015-12-29 | Merck Sharp & Dohme Corp. | C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use |
| AU2012298983A1 (en) | 2011-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | 2-spiro-substituted iminothiazines and their mono-and dioxides as BACE inhibitors, compositions and their use |
| EP3233077A4 (en) | 2014-12-19 | 2018-08-08 | The Broad Institute Inc. | Dopamine d2 receptor ligands |
| EP3233799B1 (en) | 2014-12-19 | 2021-05-19 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4762155B2 (ja) * | 2004-01-08 | 2011-08-31 | エフ．ホフマン−ラ ロシュ アーゲー | ジアザ−スピロピペリジン誘導体 |
| JP2006044497A (ja) * | 2004-08-05 | 2006-02-16 | Toyota Motor Corp | 車輪情報処理装置 |
| CA2583342A1 (en) * | 2004-10-13 | 2006-04-27 | Merck And Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer's disease |
| AU2006270084B2 (en) * | 2005-07-18 | 2011-08-25 | Merck Sharp & Dohme Corp. | Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| JP2010502705A (ja) * | 2006-09-07 | 2010-01-28 | メルク エンド カムパニー インコーポレーテッド | アルツハイマー病の治療用としてのスピロピペリジンベータセクレターゼ阻害剤 |
| US8377954B2 (en) * | 2007-01-04 | 2013-02-19 | Merck, Sharp & Dohme, Corp | Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
-
2009
- 2009-05-04 MX MX2010012066A patent/MX2010012066A/es not_active Application Discontinuation
- 2009-05-04 AT AT09742523T patent/ATE537178T1/de active
- 2009-05-04 JP JP2011508035A patent/JP2011519913A/ja not_active Withdrawn
- 2009-05-04 CN CN2009801261947A patent/CN102083841A/zh active Pending
- 2009-05-04 US US12/990,739 patent/US20110046160A1/en not_active Abandoned
- 2009-05-04 CA CA2721786A patent/CA2721786A1/en not_active Abandoned
- 2009-05-04 EP EP09742523A patent/EP2300484B1/en active Active
- 2009-05-04 EA EA201001566A patent/EA201001566A1/ru unknown
- 2009-05-04 NZ NZ588589A patent/NZ588589A/en not_active IP Right Cessation
- 2009-05-04 KR KR1020107024794A patent/KR20110000749A/ko not_active Ceased
- 2009-05-04 ES ES09742523T patent/ES2375913T3/es active Active
- 2009-05-04 BR BRPI0912433A patent/BRPI0912433A2/pt not_active Application Discontinuation
- 2009-05-04 AP AP2010005456A patent/AP2010005456A0/xx unknown
- 2009-05-04 AU AU2009245322A patent/AU2009245322B2/en not_active Ceased
- 2009-05-04 WO PCT/IB2009/051815 patent/WO2009136350A1/en not_active Ceased
-
2010
- 2010-10-18 IL IL208793A patent/IL208793A0/en unknown
- 2010-10-21 DO DO2010000317A patent/DOP2010000317A/es unknown
- 2010-10-26 CR CR11759A patent/CR11759A/es not_active Application Discontinuation
- 2010-11-05 SV SV2010003725A patent/SV2010003725A/es not_active Application Discontinuation
- 2010-11-05 MA MA33328A patent/MA32290B1/fr unknown
- 2010-11-09 EC EC2010010597A patent/ECSP10010597A/es unknown
- 2010-11-11 CO CO10141834A patent/CO6321280A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102083841A (zh) | 2011-06-01 |
| CR11759A (es) | 2010-11-22 |
| AU2009245322B2 (en) | 2011-07-14 |
| DOP2010000317A (es) | 2010-11-15 |
| CO6321280A2 (es) | 2011-09-20 |
| SV2010003725A (es) | 2011-07-05 |
| MA32290B1 (fr) | 2011-05-02 |
| US20110046160A1 (en) | 2011-02-24 |
| WO2009136350A1 (en) | 2009-11-12 |
| EP2300484A1 (en) | 2011-03-30 |
| ECSP10010597A (es) | 2010-12-30 |
| EP2300484B1 (en) | 2011-12-14 |
| AU2009245322A1 (en) | 2009-11-12 |
| NZ588589A (en) | 2012-07-27 |
| JP2011519913A (ja) | 2011-07-14 |
| BRPI0912433A2 (pt) | 2015-12-22 |
| EA201001566A1 (ru) | 2011-04-29 |
| KR20110000749A (ko) | 2011-01-05 |
| ES2375913T3 (es) | 2012-03-07 |
| CA2721786A1 (en) | 2009-11-12 |
| MX2010012066A (es) | 2010-12-06 |
| ATE537178T1 (de) | 2011-12-15 |
| AP2010005456A0 (en) | 2010-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0910003D0 (en) | Novel compounds for the treatment of neurodegenerative diseases | |
| GB201021103D0 (en) | New compounds for the treatment of neurodegenerative diseases | |
| ZA201402424B (en) | 1- arylcarbonyl -4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| PL2512470T3 (pl) | Oszczędzające ppar tiazolidynodiony i połączenia do leczenia chorób neurodegeneracyjnych | |
| EP2004204A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| GB0921075D0 (en) | Novel combination of the therapeutic agents | |
| IL253293B (en) | Desferrioxamine complexes of metals for the treatment of diseases related to the immune system | |
| IL208357A0 (en) | Spiro-indole derivatives for the treatment of parasitic diseases | |
| GB0806794D0 (en) | Therapeutic compounds | |
| IL208793A0 (en) | Novel class of spiro piperidines for the treatment of neurodegenerative diseases | |
| GB0804755D0 (en) | Therapeutic compounds | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| IL201449A0 (en) | Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases | |
| IL241253A0 (en) | Peptides for the treatment of neurodegenerative diseases | |
| ZA201009268B (en) | Substituted tricyclic derivatives against neurodegenerative diseases | |
| ZA200907827B (en) | Novel combinations of neramexane for the treatment of neurodegenerative disorders | |
| GB0809476D0 (en) | Treatment of neurodegenerative disorders | |
| ZA200908724B (en) | Spiro compounds for treatment of inflammatory disorders | |
| GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
| WO2010083208A9 (en) | Treating neuropsychiatric diseases | |
| GB0906026D0 (en) | Therapeutic compounds | |
| GB0715255D0 (en) | Thiadiazol-piperazinyl derivatives for the treatment of neurodegenerative diseases | |
| GB0900712D0 (en) | Therapeutic compounds | |
| GB0911266D0 (en) | Therapeutic compounds | |
| GB0916308D0 (en) | Therapeutic compounds |